Sumatriptan patch is an alternative method of taking your Imitrex. Or GImitrex, as the case might be.
It's called NP101 and it's being developed by NuPathe Inc. Apparently, some data on Phase 1 clinical trial was presented on 50th Annual Scientific Meeting of the American Headache Society of which yours truly provided an extensive coverage. It's good to hear about it later than never.
The Press Release contains lots of Latin words and none of them is Salsa. So, lets translate.
The Pluses:
- The Sumatriptan patch delivers the drug into the bloodstream faster that a pill or a nasal spray with the same ingredients.
- It's also more reliable than a pill or a nasal spray that depend on patient's condition.
- Side-effects, such us flushing or pain and pressure sensations were not reported with the patch, while present after injection and the pill.
- Skin-itch. (Presented in the report as pruritus.)
- Skin-irritation. (Presented in the report as erythema.)
- The people who market the patch apparently can't speak proper English without hiding the negative bits behind Latin words (see above) and as such cannot be trusted :P .
The NP101 patch is going into Phase III clinical trials son. That is unless they realize that migraine people have more sensitive skin than normals and will have to re-formulate the patch with extra Aloe Oil.
Other than that, the future FDA approval seems to be a done deal. We can reasonably predict Sumatriptan Patch will hit the pharmacies inside a year's time.
Related Articles:
Imitrex - Powder Nasal Delivery vs Subcutaneous Needle-less Injections
Your Hair Hurts? Read This
Link: NuPathe Reports Positive Phase I Results for NP101, a Novel Transdermal Patch for Acute Migraine




